PrimerDesign

FORMER TOP A*STAR SCIENTISTS LAUNCH ABASIA, A SINGAPORE-BASED REAGENTS MANUFACTURER, TO SUPPORT INCREASED TESTING LOCALLY

Retrieved on: 
Tuesday, June 1, 2021

As COVID-19 testing becomes part of Singapores new normal, locally based AbAsia is poised to ensure Singapore has a consistent supply of critical reagents to make COVID-19 test kits.

Key Points: 
  • As COVID-19 testing becomes part of Singapores new normal, locally based AbAsia is poised to ensure Singapore has a consistent supply of critical reagents to make COVID-19 test kits.
  • This will help the country meet the growing demand for COVID-19 in-vitro diagnostic kits and polymerase chain reaction (PCR) test kits.
  • The companys high quality, reliable and accessible reagents will also be used to drive advances in R&D in biotechnology and cancer research in the future.
  • This venture will also support the country as we seek to roll out routine and large-scale testing to keep the country safe.

Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit

Retrieved on: 
Wednesday, August 19, 2020

Avalon is also working with Cellex to source manufacturing facilities and to develop next generation COVID-19 detection kits.

Key Points: 
  • Avalon is also working with Cellex to source manufacturing facilities and to develop next generation COVID-19 detection kits.
  • The rapid spread of COVID-19 around the world has driven demand for SARS-CoV-2 detection, especially for rapid antibody testing, stated David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon.
  • The global COVID-19 rapid test kit market is expected to reach $3.52 billion by the end of 2020.
  • We look forward to leveraging our international network of strategic partners to commercialize this differentiated COVID-19 rapid test.

COVID-19 Rapid Test Kits Global Market Report 2020-30: COVID-19 Implications and Growth

Retrieved on: 
Tuesday, July 21, 2020

The COVID-19 rapid test kits market consists of sales of rapid test kits used for COVID-19 diagnosis and detection.

Key Points: 
  • The COVID-19 rapid test kits market consists of sales of rapid test kits used for COVID-19 diagnosis and detection.
  • The COVID-19 rapid test kits are either rapid antigen test kits or rapid antibody test kits manufactured by the entities that manufacture in-vitro rapid diagnostic tests in the medical equipment industry.
  • The companies involved in manufacturing these rapid test kits are primarily engaged in designing, research and production of the rapid test kits which are used in hospitals and clinics, home care, diagnostic laboratories and more.
  • The COVID19 rapid test kits market covered in this report is segmented by test type into rapid antigen test; rapid antibody test; others.

COVID-19 Detection Test Kits & Consumables Global Market Report 2020-30: COVID 19 Implications and Growth

Retrieved on: 
Monday, July 20, 2020

The market for COVID19 detection test kits & consumables consists of sales of detection test kits and consumables used for the identification of novel coronavirus (SARS-CoV-2).

Key Points: 
  • The market for COVID19 detection test kits & consumables consists of sales of detection test kits and consumables used for the identification of novel coronavirus (SARS-CoV-2).
  • North America is anticipated to be the largest region in the COVID-19 detection test kits and consumables market by the end of 2020.
  • The market for COVID19 detection test kits & consumables market covered in this report is segmented by kits into viral load testing kits (qPCR and rt-PCR); virus-neutralizing assay kits; antibody detection kits (ELISA); viral antigen detection test kits; others.
  • The escalating demand for cost-effective and quick COVID-19 detection kits coupled with the easing of regulatory processes for COVID-19 detection kits contributed to the growth of COVID-19 detection kits and consumables market.

Datametrex Sold $1.5m Test Kits and Provides 90 Day Corporate Update on COVID-19 With Sales Outlook

Retrieved on: 
Thursday, June 18, 2020

The Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies, for total gross sales of approximately $1.5 million CAD.

Key Points: 
  • The Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies, for total gross sales of approximately $1.5 million CAD.
  • Datametrex has little or no upfront costs associated with the sale of these test kits.
  • Since May 15th, Datametrex has generated gross sales of $500,000 with the sale of 10,000 test kits and one (1) PCR machine to a large Canadian mining company with operations in West Africa.
  • Since June 8th, Datametrex has sold $810,000 with initial orders comprising of 12,000 test kits and six (6) PCR machines to two Canadian companies.

Global Real Time PCR (qPCR) Market was Estimated to be US$ 4,154.9 Mn in 2018 and is Expected to Grow at a CAGR of 8.8% Over the Forecast Period, Says Absolute Markets Insights

Retrieved on: 
Thursday, April 23, 2020

Rise in COVID-19 pandemic is increasing the demand for real time PCR (qPCR) across the globe.

Key Points: 
  • Rise in COVID-19 pandemic is increasing the demand for real time PCR (qPCR) across the globe.
  • Real time PCR (qPCR) is the standardized COVID-19 detection kit across the world.
  • Limited supply of real time PCR (qPCR) testing kits in various countries is leading healthcare organizations to search for innovative testing solutions.
  • Key Findings of the Report:
    The use of Real Time PCR (qPCR) (qPCR) for virus and bacterial analysis is expected to grow significantly over the forecast period.

Global Real Time PCR (qPCR) Market was Estimated to be US$ 4,154.9 Mn in 2018 and is Expected to Grow at a CAGR of 8.8% Over the Forecast Period, Says Absolute Markets Insights

Retrieved on: 
Thursday, April 23, 2020

Rise in COVID-19 pandemic is increasing the demand for real time PCR (qPCR) across the globe.

Key Points: 
  • Rise in COVID-19 pandemic is increasing the demand for real time PCR (qPCR) across the globe.
  • Real time PCR (qPCR) is the standardized COVID-19 detection kit across the world.
  • Limited supply of real time PCR (qPCR) testing kits in various countries is leading healthcare organizations to search for innovative testing solutions.
  • Key Findings of the Report:
    The use of Real Time PCR (qPCR) (qPCR) for virus and bacterial analysis is expected to grow significantly over the forecast period.